1. "David Solit"
  2. "Department of Medicine"
Formats
  1. Meeting Abstract (371)
  2. Journal Article (345)
  3. Editorial (8)
  4. Research Letter (4)
  5. Book Section (3)
  6. Review (3)
  7. Correspondence (2)
  8. Conference Paper (1)
  9. Guidelines (1)
Groups
  1. Department of Medicine (738)
  2. GSK Faculty (738)
  3. Genitourinary Oncology Service (738)
  4. Human Oncology and Pathogenesis Program (738)
  5. Solid Tumor Oncology Division (738)
  6. Surgery (286)

More Groups

People
  1. David Solit (738)
  2. Michael Berger (297)
  3. Hikmat Al-Ahmadie (171)
  4. Gopakumar Iyer (169)
  5. Neal Rosen (155)
  6. Nikolaus Schultz (136)

More People

Years
  1. 2024 (11)
  2. 2023 (39)
  3. 2022 (44)
  4. 2021 (47)
  5. 2020 (59)
  6. 2019 (68)

More Years

Publications
  1. Journal of Clinical Oncology (153)
  2. Cancer Research (99)
  3. Clinical Cancer Research (74)
  4. Laboratory Investigation (39)
  5. Modern Pathology (35)
  6. Cancer Discovery (24)

More Publications

Publishers
  1. American Association for Cancer Research (216)
  2. American Society of Clinical Oncology (168)
  3. Nature Publishing Group (92)
  4. Nature Research (37)
  5. Elsevier Inc. (31)
  6. Wiley Blackwell (25)

More Publishers

Results (738)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ERBB2 alterations in non-muscle invasive bladder cancer are associated with a distinct genomic signature
    Meeting Abstract

    Alam, S. M.; Tallman, J.; Koll, F.; D'Souza, N.; de Jesus Escano, M.; Donahue, T.; Goh, A.; Sarungbam, J.; Berger, M.; Schultz, N.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Genomic characterization of high-grade Ta urothelial carcinoma with and without carcinoma in situ
    Meeting Abstract

    Tallman, J. E.; Alam, S. M.; Koll, F.; Baky, F. J.; D'Souza, N.; de Jesus Escano, M.; Donahue, T. F.; Goh, A. C.; Sarungbam, J.; Berger, M. F.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Comutational patterns in FGFR3-altered non-muscle invasive bladder cancer influence recurrence and progression
    Meeting Abstract

    D'Souza, N.; de Jesus Escano, M.; Alam, S. M.; Gao, S.; Tang, X.; Goh, A.; Bochner, B. H.; Solit, D.; Iyer, G.; Al-Ahmadie, H.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Carcinoma in situ and urinary cytology as an indicator of minimal residual disease in patients with non-muscle invasive bladder cancer treated with BCG
    Meeting Abstract

    Katims, A. B.; D'Souza, N.; De Jesus Escaño, M. R.; Gokturk, G.; Basar, M.; Solit, D. B.; Iyer, G.; Bochner, B. H.; Goh, A.; Donahue, T. A.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Clinical, molecular and immunohistochemical profiles of clear cell adenocarcinoma of the urinary tract
    Meeting Abstract

    Koll, F.; Rammal, R.; Chen, Z.; Basar, M.; Alam, S. M.; Tallman, J. E.; Pietzak, E.; Dalbagni, G.; Donahue, T.; Donat, S. M.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Development of a genomic prediction model for upper tract urothelial carcinoma stage
    Meeting Abstract

    Katims, A. B.; Lavery, J. A.; Ostrovnaya, I.; Bochner, B. H.; Dalbagni, G.; Donahue, T. A.; Donat, S. M.; Herr, H. W.; Pietzak, E. J.; Al-Ahmadie, H.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • BRAF — A tumour-agnostic drug target with lineage-specific dependencies
    Review

    Hanrahan, A. J.; Chen, Z.; Rosen, N.; Solit, D. B.
    Nature Reviews Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Ensuring successful biomarker studies in bladder preservation clinical trials for non-muscle invasive bladder cancer
    Guidelines

    McConkey, D. J.; Baumann, B. C.; Greenberg, S. C.; DeGraff, D. J.; Delacroix, S. E.; Efstathiou, J. A.; Foster, J.; Groshen, S.; Kadel, E. E.; Khani, F.; more...
    Bladder Cancer (2024)

    Fulltext@MSK | Save
  • Convergent evolution of BRCA2 reversion mutations under therapeutic pressure by PARP inhibition and platinum chemotherapy
    Journal Article

    Walmsley, C. S.; Jonsson, P.; Cheng, M. L.; McBride, S.; Kaeser, C.; Vargas, H. A.; Laudone, V.; Taylor, B. S.; Kappagantula, R.; Baez, P.; more...
    npj Precision Oncology (2024)

    Fulltext@MSK | Save
  • Targeting HER2-mutant metastatic cervical cancer with neratinib: Final results from the phase 2 SUMMIT basket trial
    Journal Article

    Friedman, C. F.; D'Souza, A.; Bello Roufai, D.; Tinker, A. V.; de Miguel, M.; Gambardella, V.; Goldman, J.; Loi, S.; Melisko, M. E.; Oaknin, A.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save